Answers are grounded in this paper and cite their sources.
Lipid nanoparticles (LNPs) are regarded as a promising delivery vehicle for small interfering RNA (siRNA) for the treatment of acute liver failure. However, current LNPs show suboptimal lysosomal escape ability and biodegradability. Monoglycerides used as co-lipids show excellent lysosomal escape ability and biodegradability. However, they lack ionizable heads and only have a single hydrophobic tail. Accordingly, we design and synthesize five new triglyceride-mimetic ionizable lipids featuring variable fatty acid tail lengths and saturation levels, derived from triglyceride-like ionizable lipids that have two fatty acid tails and a tertiary amine. The ionizable lipids are susceptible to lipase-mediated degradation, thereby enhancing the biosafety of LNPs. Notably, among the synthetic lipids, 3-TG-OA displays distinct advantages in cellular internalization, lysosomal escape, biodistribution, and gene silencing efficacy. Our findings provide novel insights into the structure−activity relationship of fatty acid tails and establish a robust non-viral delivery platform for siRNA delivery.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: